California-based researchers develop a test that can detect the coronavirus using gene-editing technology and a modified mobile phone camera.
Category: genetics
But people need to be kept at the centre of it.
There is more than one reason that we need to reforest Planet Earth. Less than a fifth of Earth’s original forests have survived the rise of humans since the last glaciation, and over half of them are in just five countries (see figure below).
The biggest effect from loss of forests is loss of habitat and the resultant loss of biodiversity, even if you don’t care about climate change. We’re burning billions of acres of pristine Indonesian rain forests to plant palm oil trees (Scientific American) just to get a cooking oil with a better shelf life.
Forest biodiversity encompasses not just trees, but the multitude of plants, animals and microorganisms that inhabit forested areas — and their associated genetic diversity. Over a billion humans depend on dense forests for their survival, although all humans depend on forests in some degree for some aspect of their lives.
Researchers have made a breakthrough genetic discovery into the cause of a spectrum of severe neurological conditions.
A research study, led by the Murdoch Children’s Research Institute (MCRI) and gracing the cover of and published in the October edition of Human Mutation, found two new mutations in the KIF1A gene cause rare nerve disorders.
MCRI researcher Dr. Simranpreet Kaur said mutations in the KIF1A gene caused ‘traffic jams’ in brain cells, called neurons, triggering a devastating range of progressive brain disorders. KIF1A-Associated Neurological Disorders (KAND) affects about 300 children worldwide.
Anxious couples are approaching fertility doctors in the US with requests for a hotly debated new genetic test being called “23andMe, but on embryos.”
The baby-picking test is being offered by a New Jersey startup company, Genomic Prediction, whose plans we first reported on two years ago.
The company says it can use DNA measurements to predict which embryos from an IVF procedure are least likely to end up with any of 11 different common diseases. In the next few weeks it’s set to release case studies on its first clients.
One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, remove, or change a gene within a cell with great precision. The method is already being tested or used for the treatment of patients with sickle cell anemia and cancers such as multiple myeloma and liposarcoma, and today, its creators Emmanuelle Charpentier and Jennifer Doudna received the Nobel Prize in chemistry.
While gene editing is remarkably precise in finding and altering genes, there is still no way to target treatment to specific locations in the body. The treatments tested so far involve removing blood stem cells or immune system T cells from the body to modify them, and then infusing them back into a patient to repopulate the bloodstream or reconstitute an immune response—an expensive and time-consuming process.
Building on the accomplishments of Charpentier and Doudna, Tufts researchers have for the first time devised a way to directly deliver gene-editing packages efficiently across the blood brain barrier and into specific regions of the brain, into immune system cells, or to specific tissues and organs in mouse models. These applications could open up an entirely new line of strategy in the treatment of neurological conditions, as well as cancer, infectious disease, and autoimmune diseases.
Selection of just two scientists will stir controversy, given patent fight over genome editor’s discovery.
The genetic editing technique has contributed to new cancer therapies and has the potential to be used in curing inheritable diseases.
Two women were awarded the Nobel Prize in chemistry Wednesday for their pioneering work on genome editing, which has the life-saving potential to be used to cure genetic diseases.el Prize in chemistry Wednesday for their pioneering work on genome editing, which has the life-saving potential to be used to cure genetic diseases.el Prize in chemistry on Wednesday for developing a method for genome editing that could be used to cure many diseases.
A newly identified genetic factor allows adult skin to repair itself like the skin of a newborn babe. The discovery by Washington State University researchers has implications for better skin wound treatment as well as preventing some of the aging process in skin.
In a study, published in the journal eLife on September 29, 2020, the researchers identified a factor that acts like a molecular switch in the skin of baby mice that controls the formation of hair follicles as they develop during the first week of life. The switch is mostly turned off after skin forms and remains off in adult tissue. When it was activated in specialized cells in adult mice, their skin was able to heal wounds without scarring. The reformed skin even included fur and could make goosebumps, an ability that is lost in adult human scars.
“We were able to take the innate ability of young, neonatal skin to regenerate and transfer that ability to old skin,” said Ryan Driskell, an assistant professor in WSU’s School of Molecular Biosciences. “We have shown in principle that this kind of regeneration is possible.”
When the brain forms a memory of a new experience, neurons called engram cells encode the details of the memory and are later reactivated whenever we recall it. A new MIT study reveals that this process is controlled by large-scale remodeling of cells’ chromatin.
This remodeling, which allows specific genes involved in storing memories to become more active, takes place in multiple stages spread out over several days. Changes to the density and arrangement of chromatin, a highly compressed structure consisting of DNA and proteins called histones, can control how active specific genes are within a given cell.
“This paper is the first to really reveal this very mysterious process of how different waves of genes become activated, and what is the epigenetic mechanism underlying these different waves of gene expression,” says Li-Huei Tsai, the director of MIT’s Picower Institute for Learning and Memory and the senior author of the study.
Summary: The ability to foster and form secure interpersonal attachments can mitigate some of the genetic risks associated with PTSD.
Source: Yale
Researchers at Yale and elsewhere previously identified a host of genetic risk factors that help explain why some veterans are especially susceptible to the debilitating symptoms of post-traumatic stress disorder (PTSD).